Literature DB >> 19591786

Managing lupus patients during pregnancy.

Guillermo Ruiz-Irastorza1, Munther A Khamashta.   

Abstract

Pregnancy still constitutes a major challenge for women with systemic lupus erythematosus. Coordinated medical/obstetric care is essential to maximise the chance of success. Pregnancy should be planned in advance, following a pre-conceptional visit in which the specific risk for complications can be assessed. Previous complicated pregnancies, renal disease, irreversible damage, anti-phospholipid antibodies and treatment with high-dose steroids are adverse features. Pregnancy should be discouraged in women with symptomatic pulmonary hypertension, heart failure, severe restrictive pulmonary disease, severe chronic renal failure and recent serious lupus activity. Treatment is based on hydroxychloroquine, low-dose steroids, azathioprine and in patients with anti-phospholipid antibodies, low-dose aspirin+/-low molecular weight heparin. Close surveillance, with monitoring of blood pressure, proteinuria and placental blood flow by Doppler studies helps the early diagnosis and treatment of complications such as pre-eclampsia and foetal distress. Post-partum follow-up is also essential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591786     DOI: 10.1016/j.berh.2009.04.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  4 in total

Review 1.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Update on systemic lupus erythematosus pregnancy.

Authors:  Irene Iozza; Stefano Cianci; Angela Di Natale; Giovanna Garofalo; Anna Maria Giacobbe; Elsa Giorgio; Maria Antonietta De Oronzo; Salvatore Politi
Journal:  J Prenat Med       Date:  2010-10

Review 3.  Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital.

Authors:  Haruko Ideguchi; Shigeru Ohno; Takeaki Uehara; Yoshiaki Ishigatsubo
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

4.  Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.

Authors:  Maria Laura Bertolaccini; Gregorio Contento; Ross Lennen; Giovanni Sanna; Philip J Blower; Michelle T Ma; Kavitha Sunassee; Guillermina Girardi
Journal:  J Autoimmun       Date:  2016-05-06       Impact factor: 7.094

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.